Professional
Added to YB: 2023-12-13
Pitch date: 2023-12-06
ICO.ST [bullish]
Iconovo AB (publ)
-86.92%
current return
Author Info
We perform researched powered investment banking with a belief that Scandinavia will be a hotspot for the major future innovations within tech and lifescience. Visit their website.
Company Info
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; ICOone single-dose disposable dry powder inhaler; and ICOone nasal single-dose dry powder inhaler now for nasal use.
Market Cap
SEK 177.5M
Pitch Price
SEK 9.33
Price Target
23.00 (+1785%)
Dividend
N/A
EV/EBITDA
-4.89
P/E
-3.02
EV/Sales
5.13
Sector
Health Care Equipment and Supplies
Category
growth
Iconovo - Inhale the Future
Here is a condensed version of the Iconovo stock pitch in under 280 characters: Iconovo: Swedish medtech w/ inhaler tech. Multiple revenue streams from generics of Symbicort & Breo/Relvar launching 2025-27. Significant upside in DCF range (6.5-42 SEK base case 23) vs current low valuation of 1-1.3x sales. Key risks: financing needs & partner dependence.
Read full article (7 min)